Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

KU 59403

😃Good
Catalog No. T15673Cas No. 845932-30-1
Alias KU-59403, KU59403

KU 59403 is a selective and potent ATM inhibitor with antitumor and anticancer activity, inhibits ATM, DNA-PK and PI3K, and is often used in combination therapy with PARP or ATR inhibitors to slow the progression of cancer.

KU 59403

KU 59403

😃Good
Purity: 99.10%
Catalog No. T15673Alias KU-59403, KU59403Cas No. 845932-30-1
KU 59403 is a selective and potent ATM inhibitor with antitumor and anticancer activity, inhibits ATM, DNA-PK and PI3K, and is often used in combination therapy with PARP or ATR inhibitors to slow the progression of cancer.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
25 mg$88210-14 weeks10-14 weeks
50 mg$1,17010-14 weeks10-14 weeks
100 mg$1,77010-14 weeks10-14 weeks
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.10%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
KU 59403 is a selective and potent ATM inhibitor with antitumor and anticancer activity, inhibits ATM, DNA-PK and PI3K, and is often used in combination therapy with PARP or ATR inhibitors to slow the progression of cancer.
Targets&IC50
ATM:3 nM
In vitro
In LoVo, HCT116, and SW620, U2OS, and MDA-MB-231 cells, KU 59403 (1 μM; 16 hours) exhibited at least 1000-fold specificity for ATM over other tested members of the PI3K family[1].
In vivo
KU59403 at a daily dose of 12.5 mg/kg induces sensitization, while increasing the dose to 25 mg/kg twice daily results in the greatest chemo-sensitisation. Without significantly increased toxicity, it exhibits a 3-fold increase in BMY-40481-induced tumor growth delay in SW620 and HCT116-N7 xenografts [1].
SynonymsKU-59403, KU59403
Chemical Properties
Molecular Weight564.72
FormulaC29H32N4O4S2
Cas No.845932-30-1
SmilesCN1CCN(CCC(=O)Nc2ccc3Sc4c(Sc3c2)cccc4-c2cc(=O)cc(o2)N2CCOCC2)CC1
Relative Density.1.368 g/cm3 (Predicted)
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 5 mg/mL (8.85 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.7708 mL8.8539 mL17.7079 mL88.5395 mL
5 mM0.3542 mL1.7708 mL3.5416 mL17.7079 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy KU 59403 | purchase KU 59403 | KU 59403 cost | order KU 59403 | KU 59403 chemical structure | KU 59403 in vivo | KU 59403 in vitro | KU 59403 formula | KU 59403 molecular weight